Frank Ruffo

Insider Reports History

Entity
Individual
Location
C/O Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Ruffo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Financial Officer Common Stock 202K $212K $1.05 Mar 10, 2022 Direct

Insider Reports Filed by Frank Ruffo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Mar 10, 2022 1 -$199K 4 Mar 14, 2022 Chief Financial Officer
ACRS Aclaris Therapeutics, Inc. Mar 1, 2022 8 $0 4 Mar 3, 2022 Chief Financial Officer
ACRS Aclaris Therapeutics, Inc. Feb 9, 2022 1 -$17.6K 4 Feb 11, 2022 Chief Financial Officer
ACRS Aclaris Therapeutics, Inc. Feb 1, 2022 2 $0 4 Feb 3, 2022 Chief Financial Officer
ACRS Aclaris Therapeutics, Inc. Jun 1, 2021 4 -$325K 4 Jun 2, 2021 Chief Financial Officer